News Quantified

SMMT – summit therapeutics inc. (US:NASDAQ)

Summit Therapeutics Inc. (NASDAQ: SMMT) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $35.00 price target on the stock.

1/7

07:00 am

smmt

Medium

Summit Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Where Will Summit Therapeutics Be in 5 Years? [Yahoo! Finance]

3 Stocks That Could Turn $1,000 into $5,000 by 2030 [Yahoo! Finance]

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Live Event: Join our next subscriber-only event: "The Data Driven Investor"

Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}